Comparative analysis of the factors associated with citation and media coverage of clinical research

Abstract

Our objective was to study the relationship between the design and content of randomized clinical trials (RCTs) and the subsequent number of citations in the medical literature and attention in online news and social media. We studied RCTs published during 2014 in five highly cited medical journals. This was a retrospective review focusing on characteristics of the individual trials and measures of citation and lay media attention. Primary outcome measures included citation count and Altmetric® scores (a composite score measuring attention in news, blogs, Twitter®, and Facebook®). Two hundred and forty two RCTs were included in the final analysis. Trial characteristics that were positive predictors of citation count included investigation of Hepatitis C treatment (r = 0.35, p < 0.001), private funding (r = 0.24, p < 0.001), mortality-related endpoint (r = 0.22, p < 0.001), and research setting within the United States (r = 0.13, p < 0.001). The trial characteristic that positively predicted Altmetric score was the population size potentially affected (r = 0.39, p < 0.001). The only negative predictor of citation count was the size of the population potentially affected (r = −0.21, p < 0.001). Negative predictors of the Altmetric score included investigation of Hepatitis C treatment (r = −0.21, p < 0.001) and private funding (r = −0.13, p < 0.001). While correlation magnitudes were weak, the predictors of biomedical literature citation and non-academic media coverage were different. These predictors may affect editorial decisions and, given the rising influence of health journalism, further study is warranted.